Advertisement

Topics

Ipsidy Announces Results for First Quarter 2017

04:20 EDT 7 Aug 2017 | PR Newswire

LONG BEACH, New York, August 7, 2017 /PRNewswire/ --

Ipsidy Inc. (http://www.ipsidy.com) [OTC:IDGS], (formerly known as ID Global Solutions Corporation), a provider of secure, biometric identification, identity management and electronic transaction processing services, today announced its results for the quarter ended March 31, 2017. 

Financial Highlights for the Quarter Ended March 31, 2017 

● Total revenue for the quarter was $0.6 million, compared to $0.3 million for the quarter in 2016.

● Net loss for the quarter was $8.7 million, compared to net income of $7.7 million for 2016 (The net income in 2016 was driven by a $12.9 million gain on the reduction of the derivative liability).

● Basic and diluted net loss per share for the quarter was $0.03 cents, compared to basic net income per share of $0.04 cents and diluted net loss per share of $0.02 cents for 2016.

● Adjusted EBITDA loss for the quarter was $1.6 million, compared to $1.0 million in 2016, as the Company invested in people, infrastructure and technology to support on-going and future operations.

● Converted outstanding debt and accrued interest in the amount of approximately $6.3 million into approximately 84.8 million shares of common stock.

● Repaid an additional $0.3 million of outstanding debt, cancelled 3.6 million warrants and cancelled 2.5 million shares of the Company's common stock.

● Secured $7.0 million of additional debt and equity financing.

● Total liabilities reduced to $4.5 million compared to liabilities of $25.8 million as of December 31, 2016 and stockholders' equity increased to $12.9 million compared to a stockholders' deficit of $13.3 million as of December 31, 2016.

The combination of the above events is reflected in the substantial improvement in the Company's balance sheet and provided near-term working capital.

Refer to Table 1 for reconciliation of net income to Adjusted EBITDA (a non-GAAP measure).

Operational Highlights 

  • Announced the appointment of Philip Beck as Chairman of the Board of Directors, Chief Executive and President and Stuart Stoller as CFO on January 31, 2017.
  • Continued process improvements to the Company's MultiPay bill pay transaction platform in Colombia.
  • Continued development of the Ipsidy identity transaction platform
  • Continued development of a digital payment processing platform comprising modules for payment card issuance, HCE, tokenization, and a consumer mobile wallet as well as a merchant acquiring gateway and mobile point of sale, and mobile-commerce, beacon marketing and loyalty products.

"Ipsidy is redefining identity as a transaction so that it can be managed as easily and securely as a payment transaction," said Philip Beck, Chairman and Chief Executive Officer of Ipsidy. "We are enabling our identity transaction platform to provide our customers with reimagined solutions that let a user authenticate their identity to their own device. Our platform facilitates the processing of diverse electronic transactions, be they payments, votes, or physical or digital access, embedded with the participant's identity."

In a world that is increasingly digital and mobile, but also fraught with account breaches and stolen identity information, our vision is to offer solutions that provide pre-transaction verification of identity as well as embed identity verification within every electronic transaction message processed through our platform, or other electronic systems. We believe that it is essential that businesses and consumers know who is on the other side of an electronic transaction and have an audit trail, proving that the identity of the other party was duly verified. Ipsidy is therefore developing solutions intended to provide our customers with the next level of transaction security, control and certainty operating in both physical and digital environments leveraging mobile eco-systems. 

We are building upon our existing capabilities in biometric identification and multi-factor identity management solutions to develop an identity transaction platform for our customers. The platform enables mobile users to easily authenticate their identity to a mobile phone or portable device of their choosing (as opposed to other identity solutions requiring dedicated hardware). Our system allows participants to complete transactions with a digitally signed authentication response, including the underlying transaction data and embedded attributes of the participant's identity, accessible to the business.

Our strategy is to leverage our identity transaction platform to support a variety of vertical markets. These vertical markets include but are not limited to border security, public safety, public transportation, enterprise security, electronic payments transactions and banking. In addition, our platform is designed to be highly available and language agnostic thereby accessible to customers around the world. We believe that the various technologies that Ipsidy is developing and has acquired can be combined into a unified offering.

Ipsidy's digital mobile wallet application, or electronic account holder, will contain different services and accounts that enable users to conveniently and securely authenticate and authorize a variety of electronic transactions, using their identity. For example, our closed-loop payment account and digital issuance platform is intended to offer secure and cost-effective methods of conversion of cash and paper to electronic payments. Consumers accessing this system, using their mobile phones, electronic devices, or smart card payment tokens will be able to participate in the digital economy thereby facilitating financial inclusion for the un-banked and under banked population around the globe. Another example is for consumers and employees to use their mobile application to verify identity, in order to access secure, digital or physical environments.

Additional analysis of the Company's performance can be found in 'Management's Discussion and Analysis of Financial Condition and Results of Operations' included in the Quarterly Report on Form 10-Q for the Quarter ended March 31, 2017 filed at http://www.sec.gov and posted on the Company's investor relations website.

About Ipsidy: 

Ipsidy is a provider of secure, biometric identification, identity management and electronic transaction processing services. Ipsidy is headquartered in New York and has operating subsidiaries: MultiPay in Colombia http://www.multipay.com.co and Cards Plus in South Africa. http://www.cardsplus.co.za. In a world that is increasingly digital and mobile, our vision is to enable solutions that provide pre-transaction verification of identity as well as embed identity verification within every electronic transaction message processed through our platform, or other electronic systems. We believe that it is essential that businesses and consumers know who is on the other side of an electronic transaction and have an audit trail, proving that the identity of the other party was duly verified. We are therefore developing solutions intended to provide our customers with the next level of transaction security, control and certainty. Further information on Ipsidy can be found at http://www.ipsidy.com or contact us at sales@ipsidy.com.

Notice Regarding Forward-Looking Statements. 

Information contained in this announcement may include "forward-looking statements." All statements other than statements of historical facts included herein, including, without limitation, those regarding the financial position, business strategy, plans and objectives of management for future operations of both Ipsidy and its business partners, net revenue, net income, Adjusted EBITDA, diluted earnings per share, future service launches with customers and new initiatives and customer pipeline are forward-looking statements. Such forward-looking statements are based on a number of assumptions regarding Ipsidy present and future business strategies, and the environment in which Ipsidy expects to operate in the future, which assumptions may or may not be fulfilled in practice. Implementation of some or all of the new services referred to is subject to regulatory or other third party approvals. Actual results may vary materially from the results anticipated by these forward-looking statements as a result of a variety of risk factors, including the risk that implementation, adoption and offering of the service by customers, consumers and others may take longer than anticipated, or may not occur at all; changes in laws, regulations and practices; changes in domestic and international economic and political conditions and others. Additional risks may arise with respect to commencing operations in new countries and regions, of which Ipsidy is not fully aware at this time. See the Company's Annual Report Form 10-K for the Fiscal Year ended December 31, 2016 filed at http://www.sec.gov for other risk factors which investors should consider. These forward-looking statements speak only as to the date of this announcement and cannot be relied upon as a guide to future performance. Ipsidy expressly disclaims any obligation or undertaking to disseminate any updates or revisions to any forward-looking statements contained in this announcement to reflect any changes in its expectations with regard thereto or any change in events, conditions or circumstances on which any statement is based.

Non-GAAP Financial Information. 

The Company provides certain non-GAAP financial measures in this statement. Management believes that Adjusted EBITDA, when viewed with our results under GAAP and the accompanying reconciliations, provides useful information about our period-over-period results. Adjusted EBITDA is presented because management believes it provides additional information with respect to the performance of our fundamental business activities and is also frequently used by securities analysts, investors and other interested parties in the evaluation of comparable companies. We also rely on Adjusted EBITDA as a primary measure to review and assess the operating performance of our company and our management team in connection with our executive compensation. These non-GAAP key business indicators, which include Adjusted EBITDA, should not be considered replacements for and should be read in conjunction with the GAAP financial measures.

We define Adjusted EBITDA as GAAP net loss adjusted to exclude: (1) interest expense, (2) interest income, (3) provision for income taxes, (4) depreciation and amortization, (5) stock-based compensation expense (5) derivative income (expense) and (6) certain other items management believes affect the comparability of operating results. Please see "Adjusted EBITDA" below for more information and for a reconciliation of Adjusted EBITDA to net income, the most directly comparable financial measure calculated and presented in accordance with GAAP.

                                            Table 1 


   
                     Reconciliation of Net Loss to Adjusted EBITDA
                                                     Quarter Ended March 31,
                                                  2017                     2016
    Net Loss                                  $ (8,669,092)            $ (7,692,510)
    Interest Expense                                604,015                  926,752
    Conversion of debt, etc.                      4,106,651                        -
    Gain on derivative liability                          -             (12,941,663)
    Depreciation and amortization                   109,534                  147,052
    Taxes                                                 -                        -
    Stock compensation                            2,294,160                3,214,732

    Adjusted EBITDA                           $ (1,554,732)              $ (960,617)


   
                                 IPSIDY INC. AND SUBSIDIARIES
                                 CONSOLIDATED BALANCE SHEETS

                                                                                     March 31,         December 31,
                                                                                       2017                 2016

                                            ASSETS


   
    Current Assets:
    Cash                                                                             $ 4,946,012           $ 689,105
    Accounts receivable, net                                                             112,634             138,359
    Current portion of net investment in direct financing lease                           48,734              44,990
    Inventory                                                                            147,816             150,679
    Other current assets                                                                 388,200             166,479
    Total current assets                                                               5,643,396           1,189,612

    Property and Equipment, net                                                          268,386             115,682
    Other Assets                                                                         693,872             358,343
    Intangible Assets, net                                                             3,388,149           3,474,291
    Goodwill                                                                           6,736,043           6,736,043
    Net investment in direct financing lease, net of current                             658,877             674,015
    Total assets                                                                    $ 17,388,723        $ 12,547,986

                                          LIABILITIES AND STOCKHOLDERS' EQUITY
    Current Liabilities:
    Accounts payable and accrued expenses                                            $ 2,089,020         $ 1,687,900
    Convertible notes payable, net                                                             -             250,000
    Derivative liability                                                                       -           8,388,355
    Capital lease obligation, current portion                                             25,071                   -
    Notes payable, net, current portion                                                   45,646             109,819
    Deferred revenue                                                                     255,657             398,680
    Total current liabilities                                                          2,415,394          10,834,754

    Long-term Liabilities:
    Convertible notes payable, net, less current maturities                                    -           2,245,596
    Notes payable, net, less current maturities                                        1,943,526           3,051,603
    Capital lease obligation, net of current portion                                     136,379
    Derivative liability, net of current portion                                               -           9,668,276
    Total long-term liabilities                                                        2,079,905          14,965,475
    Total liabilities                                                                  4,495,299          25,800,229

    Commitments and Contingencies

    Stockholders' Equity (Deficit):
    Common stock, $0.0001 par value, 500,000,000 shares
    authorized; 344,093,411 and 234,704,655 shares issued
    and outstanding as of March 31, 2017 and December 31, 2016, respectively              34,409              23,470
    Additional paid in capital                                                        70,952,037          35,341,669
    Stock subscription receivable                                                      (830,000)                   -
    Accumulated deficit                                                             (57,595,085)        (48,925,993)
    Accumulated comprehensive income                                                     332,063             308,611
    Total stockholders' equity (deficit)                                              12,893,424        (13,252,243)
    Total liabilities and stockholders' equity (deficit)                            $ 17,388,723        $ 12,547,986


   

                                 IPSIDY INC. AND SUBSIDIARIES
                            CONSOLIDATED STATEMENTS OF OPERATIONS

                                                            For the three months ended
                                                                    March 31,
                                                              2017            2016


   
    Revenues:
    Products and services                                       $ 565,545      $ 320,746
    Lease income                                                   19,144              -
    Total revenues, net                                           584,689        320,746

    Operating Expenses:
    Cost of Sales                                                 149,129        118,110
    General and administrative                                  4,255,382      4,392,886
    Research and development                                       28,948         29,072
    Depreciation and amortization                                 109,534        103,079
    Total operating expenses                                    4,543,115      4,643,147

    Loss from operations                                      (3,958,422)    (4,322,401)

    Other Income (Expense):
    (Loss) gain on derivative liability                         (452,146)     12,941,663
    Gain on extinguishment of debt                              2,802,235              -
    (Loss) on conversion of debt                              (5,978,643)              -
    (Loss) on modification of warrant(s)                        (158,327)              -
    (Loss) on modification of derivatives                       (319,770)              -
    Interest expense                                            (604,015)      (926,752)
    Other income (expense), net                               (4,710,666)     12,014,911

    Income loss before income taxes                           (8,669,092)      7,692,510

    Income Taxes                                                        -              -

    Net (loss)                                              $ (8,669,092)    $ 7,692,510

    Net (loss) income per share - Basic                          $ (0.03)         $ 0.04

    Net (loss) income per share - Diluted                        $ (0.03)       $ (0.02)

    Weighted Average Shares Outstanding - Basic               295,596,151    210,816,797

    Weighted Average Shares Outstanding - Diluted             295,596,151    270,712,051


   
                                 IPSIDY INC. AND SUBSIDIARIES
                            CONSOLIDATED STATEMENTS OF CASH FLOWS

                                                                                                     For the three months ended
                                                                                                                March 31,
                                                                                                         2017                 2016


   
    CASH FLOWS FROM OPERATING:
    Net loss                                                                                       $ (8,669,092)             $ 7,692,510
    Adjustments to reconcile net loss with cash used in operations:
    Depreciation and amortization expense                                                                109,534                 103,079
    Stock-based compensation                                                                           2,294,160               3,214,732
    Common stock issued for services                                                                      42,376                 270,000
    Amortization of debt discount                                                                        235,985   655,817       655,817
    Amortization of debt issuance costs                                                                  268,954                 167,700
    Loss (gain) on derivative liability                                                                  452,146            (12,941,663)
    Gain on extinguishment of notes payable                                                          (2,802,235)                       -
    Loss on modification of derivatives                                                                  319,770                       -
    Loss on modification of warrants                                                                     158,327                       -
    Loss on conversion of debt                                                                         5,978,643                       -
    Changes in operating assets and liabilities:
    Accounts receivable                                                                                   25,725                 731,004
    Lease receivable                                                                                      11,394                       -
    Other current assets                                                                               (226,174)                (32,200)
    Inventory                                                                                              2,863                (74,261)
    Accounts payable and accrued expenses                                                                736,535               (284,877)
    Deferred revenue                                                                                   (143,012)                (70,116)
    Net cash flows from operating activities                                                         (1,204,101)               (568,275)

    CASH FLOWS FROM INVESTING:
    Purchase of property and equipment                                                                   (4,563)                (11,307)
    Investment in other assets including work in process                                               (343,655)                (20,157)

    Cash acquired in acquisitions                                                                              -                 419,042
    Net cash flows from investing activities                                                           (348,218)                 387,578

    CASH FLOWS FROM FINANCING:
    Proceeds from issuance of notes payable and common stock                                           3,000,000                 100,000
    Payment of debt issuance cost                                                                       (86,331)                       -
    Proceeds from sale of common stock                                                                 2,880,710                       -

    Principal payments on capital lease obligations                                                      (1,957)
    Principal payments on notes payable                                                                 (14,173)                (16,372)
    Net cash flows from financing activities                                                           5,778,249                  83,628

    Effect of foreign currencies                                                                          30,977                  57,229

    Net Change in Cash                                                                                 4,256,907                (39,840)
    Cash, Beginning of Period                                                                            689,105                 349,873
    Cash, End of Period                                                                              $ 4,946,012               $ 310,033

    Supplemental Disclosure of Cash Flow Information:
    Cash paid for interest                                                                                   $ -                     $ -
    Cash paid for income taxes                                                                               $ -                     $ -

    Non-cash Investing and Financing Activities:
    Issuance of common stock for conversion of debt and related interest                            $ 21,609,673                $ 21,122

    Issuance of common stock for debt issuance costs                                                   $ 224,460                $ 76,000
    Reclassification of derivatives upon removal of price protection in warrants                     $ 7,614,974                      $-
    Reclassification of derivative liabilities upon conversion into common stock                  $ -                          $ 316,734
    Acquisition of equipment due to a capital lease                                                    $ 163,407                     $ -
    Acquisition of FIN Holdings (2016):
    Issuance of common stock as consideration                                                                $ -             $ 9,000,000
    Assumed liabilities                                                                                        -                 914,218
    Inventory                                                                                                  -               (112,408)
    Accounts receivable                                                                                        -               (311,867)
    Property and equipment                                                                                     -               (100,339)
    Intangible assets                                                                                          -             (8,970,562)
    Cash acquired                                                                                            $ -               $ 419,042



 Contacts:
 Ipsidy Inc.
 +1-407-951-8640
 
 Philip D. Beck, Chairman, CEO & President
 PhilipBeck@ipsidy.com
 
 Stuart P. Stoller, CFO
 StuartStoller@ipsidy.com

SOURCE Ipsidy Inc.

NEXT ARTICLE

More From BioPortfolio on "Ipsidy Announces Results for First Quarter 2017"

Quick Search
Advertisement
 

Relevant Topic

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...